Table 1 Baseline demographic data, clinical manifestations, and the laboratory investigations of both groups

Age (years) (mean± SD)

57.50 ± 6.48

59.40 ± 6.16

t=1.34

0.183

Gender

 Male

21 (52.5)

25 (62.5)

χ²= 0.81

0.366

 Female

19 (47.5)

15 (37.5)

Abdominal pain

39 (97.5)

37 (92.5)

FE=1.05

0.615

Fever

31 (77.5)

34 (85.0)

χ²= 0.73

0.390

Hepatic encephalopathy

8 (20.0)

9 (22.5)

χ²= 0.07

0.785

Hemoglobin (g/dl)

10.33 ± 1.34

9.83 ± 1.10

t=1.82

0.072

Platelets (cell× 103/mm³)

122.67 ± 73.03

146.62 ± 77.41

U=1.54

0.122

Total leucocytic count (cell× 103/mm³)

5.85 ± 3.42

6.51 ± 4.58

U=0.476

0.634

S. creatinine (mg/dl)

1.08 ± 0.58

1.16 ±0.40

U=1.61

0.106

S urea (mg/dl)

56.47 ± 41.81

52.19 ± 29.86

U=0.09

0.923

AST (u/l)

52.67 ± 36.43

50.70 ± 33.67

U=0.24

0.810

ALT (u/l)

41.82 ± 27.27

36.62 ±17.36

U=0.28

0.776

S. albumin (g/dl)

2.51 ± 0.50

2.61 ± 0.41

t=0.97

0.335

S. Bilirubin (mg/dl)

2.80 ± 2.68

3.82 ± 3.69

U=0.90

0.368

INR

1.56 ± 0.42

1.65 ± 0.45

t=0.86

0.389

CRP (mg/l)

38.86 ± 37.59

31.00 ±24.56

U=0.45

0.649